The licensing agreement between Serum Institute of India and Oxford University represents a significant step forward in the fight against Meningitis-B.... Apr 18
Medical devices Manufacturers have a new guideline, The Central Drugs Standard Organization (CDSCO) issued a new deadline of October 1, for the categorized medical devices ... Oct 09
Adar Poonawalla, CEO of Serum Institute of India, highlighted the potential of the vaccine to save lives in malaria-stricken regions of Africa and acknowledged ... Oct 04
The mandatory prescription of generic drugs by the new National Medical Council is poised to usher in a transformative era in healthcare. While the pros ... Aug 18
... Aug 04
10 million people die from cancer every year. By using laser and gel treatment from Lead Invent Pharma Inc., skin and oral cancer can now ... Jul 30
Latest pharma news update... Dec 30
Latest pharma news update... Oct 23
Latest Pharma Updates... Sep 06
Latest Pharma News Upate... Aug 23
Latest pharma news update... Aug 03
Latest Pharma News Update... Jul 06
Glenmark has launched Tiotropium Bromide Dry Powder Inhaler (DPI) under the brand name - Tiogiva in UK ... Jun 15
... Jun 09
The Centre took more than six months to put its act together on the domestic front and shortlisted three PSUs only by April 2021 for ... May 13
The curfew has been enforced from April 12, 9 PM till April 19, 6 am... Apr 13
Devanshi Sharma gives insight into Dissociative Identity Disorder (DID). She gives an overview to family members about the right way to deal with patients suffering ... Apr 08
This collaboration will improve the field of the animal healthcare industry... Feb 23
Top ten mid cap Indian pharma stocks , January 2021... Jan 07
... Dec 23
The licensing agreement will be effective in 33 countries throughout the European region including France, Italy, and Spain... Dec 23
The agreement that gives Astrea the ability to secure exclusive access to the Affimer technology for applications in bioprocessing... Dec 22
BioInvent and Transgene, today announced they have received regulatory approval in Belgium for a clinical trial application (CTA) for a Phase l/lla study of ... Dec 21
ObsEva, today announced topline 52-week PRIMROSE 1 and 76-week PRIMROSE 2 results of Yselty, in development for the treatment of women with heavy ... Dec 10
This collaboration will help both companies to work together to test and further optimize PeptiDream’s Growth Hormone Receptor Antagonist“GHRA†peptide candidates... Dec 09
-Advertisements-
Monday, April 29, 2024
.png)
.jpg)
